GUELPH, ON, Aug. 22, 2014 /PRNewswire/ - BIOREM Inc. (TSXV:
BRM) ("Biorem" or "the Company") today announced results for the
three month and six month periods ended June
30, 2014. Biorem's complete 2014 second quarter
financial statements and MD&A have been filed on SEDAR
(www.sedar.com).
Financial Summary:
|
|
|
|
Three-months
ended
June 30,
|
Six-months
ended
June 30,
|
( in CDN$'000
except per share data)
|
2014
|
2013
|
2014
|
2013
|
Revenue
|
2,459
|
5,010
|
4,433
|
9,195
|
Gross
profit
|
56
|
1,485
|
385
|
2,585
|
Ebitda*
|
(623)
|
507
|
(965)
|
740
|
Net earnings
(loss)
|
(835)
|
254
|
(1,366)
|
223
|
Basic earnings (loss)
per share
Diluted earnings
(loss) per share
|
(0.06)
(0.06)
|
0.02
0.01
|
(0.11)
(0.11)
|
0.02
0.01
|
*Earnings before
interest, taxes and amortization, a non IFRS financial
measure
|
Revenues for the quarter totaled $2,459,000, a 25% increase over revenues of
$1,974,000 recorded during the first
quarter of 2014 and a $2,550,000 or
51% decrease over revenues recorded during the second quarter of
2013. Year to date revenues have declined 52% to $4,433,000 compared to $9,195,000 in the same period in the prior year.
Gross profit for the quarter was 2.2% of revenue compared to
16.7% for the quarter ended March 31,
2014 and 26.9% for the quarter ended June 30, 2013. Gross profit for the quarter was
negatively impacted during the quarter by the one-time provision
for loss that was recorded against a project that requires remedial
work. In the absence of this provision for loss, gross profit for
the quarter would have been $656,000
or 23.7 % of revenue which is consistent with the gross profit
percentage achieved in previous quarters.
For the six month period gross profit decreased by $2,200,000, an 85% decrease from the gross profit
of $2,585,000 recorded for the six
months ended June 30, 2013.
Operating expenses in the quarter of $748,000 were 31% lower than the $1,088,000 of expenses recorded in the same
period in the previous year. For the six months ended June 30, 2014 operating expenses were
$1,482,000, a 29% decrease over
operating expenses of $2,073,000 in
the comparable period in 2013. The decrease in
operating expenses were largely the result of lower sales
commissions earned on the lower revenue recorded, and by
lower general and administrative costs and lower expenditures on
research and development resulting from cost reductions initiated
by the Company.
Net loss for the quarter and six months ended were $835,000, and $1,366,000 respectively compared to earnings of
$254,000 and $223,000 in 2013. On a loss per share basis
loss for the quarter was $0.06 per
share and $0.11 per share for the six
month period ended June 30, 2014.
"We had expected the quarter to be soft since orders had slowed
in the latter half of 2013. However orders are picking up along
with evidence that the overall market conditions have improved
significantly as evidenced by the growth in our backlog," said
Peter Bruijns, President & CEO.
"Biorem experienced a technology challenge on one project which
required a significant cost allocation to ensure technical
performance and this substantially affected our gross margin. The
margin reduction resulting from this allocation is not an
indication that average margins are under pressure."
The Company succeeded in booking new orders totalling
$3.8 million in the Quarter which
resulted in an order backlog at the end of June 2014 of $9.7
million.
About BIOREM Inc.
Biorem is a leading clean technology company that designs,
manufactures and distributes a comprehensive line of
high-efficiency air emissions control systems used to eliminate
odors, volatile organic compounds (VOCs), and hazardous air
pollutants (HAPs). With sales and manufacturing offices across the
continent, a dedicated research facility, a worldwide sales
representative network and more than 800 installed systems
worldwide, Biorem offers state-of-the-art technology-based products
and peace of mind for municipalities, industrial companies and
their surrounding communities. Additional information on Biorem is
available on our website at www.biorem.biz.
SOURCE Biorem Inc.